BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33975618)

  • 1. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
    Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
    Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
    Kong W; Li H; Tuma RF; Ganea D
    Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
    Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
    Shen R; Deng W; Li C; Zeng G
    Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9,10-Anhydrodehydroartemisinin Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Th1 and Th17 Cell Differentiation.
    Lv J; Zhuang W; Zhang Y; Xie L; Xiang Z; Zhao Q; Jiang X; Shen J; Du C
    Inflammation; 2021 Oct; 44(5):1793-1802. PubMed ID: 33788130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
    PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
    Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
    Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
    Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
    J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
    Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
    Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
    Kong W; Hooper KM; Ganea D
    Brain Behav Immun; 2016 Mar; 53():59-71. PubMed ID: 26541818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.
    Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis.
    Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC
    J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.